| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90AB4P MYO1D MSH2 ACSF2 DNAH7 UBA7 ATP11B KIF19 AACS MYO15A ATP2A1 ATP2A3 ATP5F1B | 2.24e-05 | 614 | 106 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | IMP dehydrogenase activity | 2.79e-05 | 2 | 106 | 2 | GO:0003938 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 7.74e-05 | 16 | 106 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.66e-04 | 4 | 106 | 2 | GO:0030899 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | STXBP5L NLGN4Y RPH3A NLGN3 TH NLGN4X SLC18A1 RIMS4 CTNNB1 UNC13A | 1.08e-06 | 264 | 106 | 10 | GO:0099504 |
| GeneOntologyBiologicalProcess | courtship behavior | 4.55e-06 | 7 | 106 | 3 | GO:0007619 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CELF6 CALB2 TRIO STXBP5L NLGN4Y MINK1 PCDHB10 PCDHB9 BCR RPH3A YTHDF1 NLGN3 TH NLGN4X RIMS4 CTNNB1 UNC13A | 5.14e-06 | 931 | 106 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CELF6 CALB2 TRIO STXBP5L NLGN4Y MINK1 PCDHB10 PCDHB9 BCR RPH3A YTHDF1 NLGN3 TH NLGN4X RIMS4 CTNNB1 UNC13A | 5.14e-06 | 931 | 106 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CELF6 CALB2 TRIO STXBP5L NLGN4Y MINK1 PCDHB10 PCDHB9 BCR RPH3A YTHDF1 NLGN3 TH NLGN4X RIMS4 CTNNB1 UNC13A | 5.75e-06 | 939 | 106 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | STXBP5L NLGN4Y RPH3A NLGN3 TH NLGN4X SLC18A1 RIMS4 CTNNB1 UNC13A | 6.17e-06 | 321 | 106 | 10 | GO:0099003 |
| GeneOntologyBiologicalProcess | vocalization behavior | 6.47e-06 | 24 | 106 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CELF6 CALB2 TRIO STXBP5L NLGN4Y MINK1 PCDHB10 PCDHB9 BCR RPH3A YTHDF1 NLGN3 TH NLGN4X RIMS4 CTNNB1 UNC13A | 9.55e-06 | 976 | 106 | 17 | GO:0099536 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.54e-05 | 10 | 106 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.11e-05 | 11 | 106 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.63e-05 | 13 | 106 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 7.04e-05 | 16 | 106 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | gonad morphogenesis | 7.82e-05 | 3 | 106 | 2 | GO:0035262 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 7.82e-05 | 3 | 106 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | protein import into mitochondrial matrix | 1.41e-04 | 20 | 106 | 3 | GO:0030150 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.56e-04 | 4 | 106 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | aminergic neurotransmitter loading into synaptic vesicle | 1.56e-04 | 4 | 106 | 2 | GO:0015842 | |
| GeneOntologyBiologicalProcess | mating behavior | 2.11e-04 | 57 | 106 | 4 | GO:0007617 | |
| GeneOntologyBiologicalProcess | positive regulation of glutamate receptor signaling pathway | 2.59e-04 | 5 | 106 | 2 | GO:1900451 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 4.91e-07 | 4 | 105 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.40e-05 | 13 | 105 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | TIM23 mitochondrial import inner membrane translocase complex | 6.58e-05 | 16 | 105 | 3 | GO:0005744 | |
| GeneOntologyCellularComponent | dendrite | PCSK5 CALB2 GOPC MYO1D NLGN4Y MINK1 BCR RPH3A WDR47 NLGN3 TH NLGN4X CTNNB1 FUBP3 | 9.90e-05 | 858 | 105 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK5 CALB2 GOPC MYO1D NLGN4Y MINK1 BCR RPH3A WDR47 NLGN3 TH NLGN4X CTNNB1 FUBP3 | 1.01e-04 | 860 | 105 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.03e-04 | 23 | 105 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.06e-04 | 107 | 105 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 2.31e-04 | 24 | 105 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | inhibitory synapse | 5.00e-04 | 31 | 105 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | migrasome | 8.79e-04 | 9 | 105 | 2 | GO:0140494 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 8.79e-04 | 9 | 105 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | microvillus membrane | 9.14e-04 | 38 | 105 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK5 CALB2 GOPC MYO1D NLGN4Y MINK1 CNKSR2 BCR RPH3A WDR47 NLGN3 TH NLGN4X CTNNB1 FUBP3 | 1.20e-03 | 1228 | 105 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | membrane protein complex | EPN3 STXBP5L TIMM23B TIMM23 BET1L KCNK12 ITGAV EMILIN1 TTC19 SYNE3 DNAJC15 SCN4A CTNNB1 ATP2A1 FKBP1B STX6 ATP5F1B | 1.25e-03 | 1498 | 105 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.33e-03 | 11 | 105 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | terminal bouton | 1.40e-03 | 96 | 105 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.50e-03 | 45 | 105 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | cell cortex region | 1.50e-03 | 45 | 105 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | presynapse | CALB2 TRIO NLGN4Y RPH3A NLGN3 TH NLGN4X SLC18A1 RIMS4 CTNNB1 UNC13A STX6 | 1.63e-03 | 886 | 105 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | SNARE complex | 2.15e-03 | 51 | 105 | 3 | GO:0031201 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 2.63e-03 | 114 | 105 | 4 | GO:0005798 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.80e-03 | 477 | 105 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.81e-03 | 278 | 105 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | inner mitochondrial membrane protein complex | 3.16e-03 | 120 | 105 | 4 | GO:0098800 | |
| GeneOntologyCellularComponent | microvillus | 3.45e-03 | 123 | 105 | 4 | GO:0005902 | |
| Domain | Nlgn | 1.62e-06 | 5 | 103 | 3 | IPR000460 | |
| Domain | NLGN4 | 3.01e-05 | 2 | 103 | 2 | IPR030025 | |
| Domain | IMP_DH | 3.01e-05 | 2 | 103 | 2 | IPR005990 | |
| Domain | Carboxylesterase_B_CS | 4.48e-05 | 13 | 103 | 3 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.67e-05 | 14 | 103 | 3 | PS00941 | |
| Domain | COesterase | 5.67e-05 | 14 | 103 | 3 | PF00135 | |
| Domain | CarbesteraseB | 5.67e-05 | 14 | 103 | 3 | IPR002018 | |
| Domain | P-type_ATPase_IIA | 9.00e-05 | 3 | 103 | 2 | IPR005782 | |
| Domain | NA-bd_OB-fold | 9.55e-05 | 83 | 103 | 5 | IPR012340 | |
| Domain | IMPDH | 1.79e-04 | 4 | 103 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 1.79e-04 | 4 | 103 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 1.79e-04 | 4 | 103 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 1.79e-04 | 4 | 103 | 2 | IPR015875 | |
| Domain | NACHT | 2.66e-04 | 23 | 103 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 2.66e-04 | 23 | 103 | 3 | IPR007111 | |
| Domain | - | 7.19e-04 | 32 | 103 | 3 | 3.40.1110.10 | |
| Domain | - | 7.19e-04 | 32 | 103 | 3 | 2.70.150.10 | |
| Domain | C2 | 7.95e-04 | 131 | 103 | 5 | PF00168 | |
| Domain | ATPase_P-typ_cyto_domN | 9.38e-04 | 35 | 103 | 3 | IPR023299 | |
| Domain | C2 | 9.72e-04 | 137 | 103 | 5 | SM00239 | |
| Domain | ATPase_P-typ_P_site | 1.02e-03 | 36 | 103 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.02e-03 | 36 | 103 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.02e-03 | 36 | 103 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.10e-03 | 37 | 103 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.10e-03 | 37 | 103 | 3 | PF00122 | |
| Domain | PDZ | 1.11e-03 | 141 | 103 | 5 | PF00595 | |
| Domain | C2 | 1.14e-03 | 142 | 103 | 5 | PS50004 | |
| Domain | Hydrolase_3 | 1.32e-03 | 10 | 103 | 2 | PF08282 | |
| Domain | PDZ | 1.37e-03 | 148 | 103 | 5 | SM00228 | |
| Domain | - | 1.45e-03 | 150 | 103 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.50e-03 | 151 | 103 | 5 | PS50106 | |
| Domain | PDZ | 1.54e-03 | 152 | 103 | 5 | IPR001478 | |
| Domain | tRNA_anti-codon | 1.92e-03 | 12 | 103 | 2 | PF01336 | |
| Domain | NA-bd_OB_tRNA | 1.92e-03 | 12 | 103 | 2 | IPR004365 | |
| Domain | C2_dom | 2.15e-03 | 164 | 103 | 5 | IPR000008 | |
| Domain | PLAC | 2.62e-03 | 14 | 103 | 2 | PF08686 | |
| Domain | CBS | 3.44e-03 | 16 | 103 | 2 | SM00116 | |
| Domain | ATPase_P-typ_TM_dom | 3.44e-03 | 16 | 103 | 2 | IPR023298 | |
| Domain | - | 3.44e-03 | 16 | 103 | 2 | 1.20.1110.10 | |
| Domain | LRR_6 | 3.47e-03 | 55 | 103 | 3 | PF13516 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.88e-03 | 17 | 103 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.88e-03 | 17 | 103 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 4.35e-03 | 18 | 103 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 4.35e-03 | 18 | 103 | 2 | SM00831 | |
| Domain | PLAC | 4.84e-03 | 19 | 103 | 2 | PS50900 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.84e-03 | 19 | 103 | 2 | IPR004014 | |
| Domain | PLAC | 4.84e-03 | 19 | 103 | 2 | IPR010909 | |
| Domain | CBS_dom | 5.36e-03 | 20 | 103 | 2 | IPR000644 | |
| Domain | CBS | 5.36e-03 | 20 | 103 | 2 | PF00571 | |
| Domain | CBS | 5.36e-03 | 20 | 103 | 2 | PS51371 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 32011705 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18628683 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.16e-07 | 4 | 108 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.16e-07 | 4 | 108 | 3 | 22671294 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 20579107 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16077734 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 17292328 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 2.90e-07 | 5 | 108 | 3 | 10996085 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 21838267 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 29724786 | ||
| Pubmed | 8.24e-07 | 102 | 108 | 6 | 10231032 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.25e-06 | 26 | 108 | 4 | 34848499 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.61e-06 | 8 | 108 | 3 | 30871858 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 23010509 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 32973045 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 26403076 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 8.14e-06 | 13 | 108 | 3 | 27050589 | |
| Pubmed | Expression of IMPDH mRNA after mycophenolate administration in male volunteers. | 9.55e-06 | 2 | 108 | 2 | 25105143 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27782075 | ||
| Pubmed | Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. | 9.55e-06 | 2 | 108 | 2 | 11050238 | |
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 9.55e-06 | 2 | 108 | 2 | 28948087 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20718729 | ||
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 9.55e-06 | 2 | 108 | 2 | 16648374 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 9.55e-06 | 2 | 108 | 2 | 19645625 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1969416 | ||
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 9.55e-06 | 2 | 108 | 2 | 15274046 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23183221 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 9.55e-06 | 2 | 108 | 2 | 37001827 | |
| Pubmed | Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice. | 9.55e-06 | 2 | 108 | 2 | 12944494 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20130090 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18189281 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2902093 | ||
| Pubmed | Disorder-associated mutations lead to functional inactivation of neuroligins. | 9.55e-06 | 2 | 108 | 2 | 15150161 | |
| Pubmed | Characterization of human type I and type II IMP dehydrogenases. | 9.55e-06 | 2 | 108 | 2 | 7903306 | |
| Pubmed | Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. | 9.55e-06 | 2 | 108 | 2 | 15622415 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7763314 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11384996 | ||
| Pubmed | Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo. | 9.55e-06 | 2 | 108 | 2 | 14766016 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26344907 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18434543 | ||
| Pubmed | Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene. | 9.55e-06 | 2 | 108 | 2 | 7896827 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20679962 | ||
| Pubmed | Hormonal regulation of mitochondrial Tim23 gene expression in the mouse mammary gland. | 9.55e-06 | 2 | 108 | 2 | 11165051 | |
| Pubmed | Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. | 9.55e-06 | 2 | 108 | 2 | 23431752 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17713475 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 9.55e-06 | 2 | 108 | 2 | 37080762 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16508939 | ||
| Pubmed | Mutants of purine metabolism in cultured mouse and hamster cells. | 9.55e-06 | 2 | 108 | 2 | 988789 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29106499 | ||
| Pubmed | NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. | 9.55e-06 | 2 | 108 | 2 | 15389766 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 9.55e-06 | 2 | 108 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 9.55e-06 | 2 | 108 | 2 | 32243781 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22989184 | ||
| Pubmed | Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. | 9.55e-06 | 2 | 108 | 2 | 18474620 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29949403 | ||
| Pubmed | Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. | 9.55e-06 | 2 | 108 | 2 | 24570023 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23851596 | ||
| Pubmed | Genetic and structural characterization of the human mitochondrial inner membrane translocase. | 1.03e-05 | 14 | 108 | 3 | 10339406 | |
| Pubmed | 1.29e-05 | 15 | 108 | 3 | 18227507 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPTLC3 TRIO STXBP5L NLGN4Y TTC21A CAPN1 MINK1 BCR TTC19 SBNO2 NLGN3 PTPN13 THRB ATP11B SUPT6H POLK | 1.45e-05 | 1489 | 108 | 16 | 28611215 |
| Pubmed | Expression of LIM-homeodomain transcription factors in the developing and mature mouse retina. | 1.58e-05 | 16 | 108 | 3 | 24333658 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPN3 ARMC3 MYO1D CAPN1 MINK1 CNKSR2 CUBN NEB ITGAV BCR PTPN13 MYO15A ATP5F1B | 1.66e-05 | 1016 | 108 | 13 | 19056867 |
| Pubmed | 2.30e-05 | 18 | 108 | 3 | 33462112 | ||
| Pubmed | 2.30e-05 | 18 | 108 | 3 | 24066094 | ||
| Pubmed | The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation. | 2.86e-05 | 3 | 108 | 2 | 28924170 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15469942 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12437925 | ||
| Pubmed | Significance of neurexin and neuroligin polymorphisms in regulating risk of Hirschsprung's disease. | 2.86e-05 | 3 | 108 | 2 | 29622757 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21994129 | ||
| Pubmed | T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly. | 2.86e-05 | 3 | 108 | 2 | 30154209 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30405116 | ||
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 2.86e-05 | 3 | 108 | 2 | 27162341 | |
| Pubmed | NOX4-TIM23 interaction regulates NOX4 mitochondrial import and metabolic reprogramming. | 2.86e-05 | 3 | 108 | 2 | 37044213 | |
| Pubmed | c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming. | 2.86e-05 | 3 | 108 | 2 | 36629054 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20061166 | ||
| Pubmed | Mutant huntingtin does not cross the mitochondrial outer membrane. | 2.86e-05 | 3 | 108 | 2 | 32821928 | |
| Pubmed | Development of renal failure in PargParp-1 null and Timm23 hypomorphic mice. | 2.86e-05 | 3 | 108 | 2 | 31326434 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 16410239 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19605777 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23585472 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 2.86e-05 | 3 | 108 | 2 | 21282647 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17317766 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10951583 | ||
| Pubmed | 3.19e-05 | 20 | 108 | 3 | 23637192 | ||
| Pubmed | Prss56, a novel marker of adult neurogenesis in the mouse brain. | 3.72e-05 | 21 | 108 | 3 | 26701169 | |
| Pubmed | 3.72e-05 | 21 | 108 | 3 | 2137249 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 PCSK5 CRYBG2 IMPDH1 TRIO TIMM23B NSD1 PAPLN BCR SBNO2 SYNE3 TMCC2 ATP2A3 | 3.96e-05 | 1105 | 108 | 13 | 35748872 |
| Pubmed | 4.93e-05 | 23 | 108 | 3 | 31850343 | ||
| Pubmed | GOPC TRIO STXBP5L MINK1 CNKSR2 BCR RPH3A WDR47 YTHDF1 TMCC2 CTNNB1 UNC13A ATP5F1B | 5.39e-05 | 1139 | 108 | 13 | 36417873 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19111522 | ||
| Pubmed | Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates. | 5.71e-05 | 4 | 108 | 2 | 22535953 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15888344 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 26772978 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 10393182 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 27248172 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 25110346 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23468870 | ||
| Cytoband | 10p12.31 | 1.89e-05 | 22 | 108 | 3 | 10p12.31 | |
| Cytoband | 2q32.3 | 3.56e-04 | 12 | 108 | 2 | 2q32.3 | |
| GeneFamily | NLR family | 1.66e-04 | 25 | 78 | 3 | 666 | |
| GeneFamily | PDZ domain containing | 5.07e-04 | 152 | 78 | 5 | 1220 | |
| GeneFamily | ATPases Ca2+ transporting | 6.49e-04 | 9 | 78 | 2 | 1209 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.54e-03 | 115 | 78 | 4 | 769 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-08 | 195 | 108 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.39e-07 | 175 | 108 | 7 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-06 | 169 | 108 | 6 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 174 | 108 | 6 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 174 | 108 | 6 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.84e-06 | 184 | 108 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 167 | 108 | 5 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.08e-05 | 171 | 108 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.08e-05 | 171 | 108 | 5 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.95e-05 | 181 | 108 | 5 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.37e-05 | 183 | 108 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.37e-05 | 183 | 108 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.37e-05 | 183 | 108 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.59e-05 | 184 | 108 | 5 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.04e-05 | 186 | 108 | 5 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.04e-05 | 186 | 108 | 5 | dfd67d67c103c942de6c8acef8d81e57a9886154 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.27e-05 | 187 | 108 | 5 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.27e-05 | 187 | 108 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 188 | 108 | 5 | b6aad90fa77fbaf80487a55415aa6c245f2d1f7e | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.50e-05 | 188 | 108 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 240923769fef18eaf73d2efa3d5f745f5533b0ce | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.99e-05 | 190 | 108 | 5 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.99e-05 | 190 | 108 | 5 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 9df9b9e91c97e504c189d6055a6aabc54ad17cec | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 191 | 108 | 5 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 1.02e-04 | 191 | 108 | 5 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 192 | 108 | 5 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 192 | 108 | 5 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | LAM-LAM-LAM+|LAM / Condition, Lineage and Cell class | 1.10e-04 | 194 | 108 | 5 | 4ba73a9145ed44896e359f6df9c1f32bbe24a189 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 194 | 108 | 5 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | LAM-LAM|LAM / Condition, Lineage and Cell class | 1.10e-04 | 194 | 108 | 5 | 4c6561a64711c72c4ef4a3e67c41d2e8d31fba57 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.16e-04 | 196 | 108 | 5 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 198 | 108 | 5 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 198 | 108 | 5 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-04 | 198 | 108 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-04 | 198 | 108 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 198 | 108 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 198 | 108 | 5 | 58f5b5e756ab4aa7234aa8d95fba564d6e8c22d9 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.21e-04 | 198 | 108 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 199 | 108 | 5 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | suprabasal_cell|World / shred by cell class for turbinate | 1.24e-04 | 199 | 108 | 5 | bfab5380ef074d14f0b5ed10851ad5c898eb9a58 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 199 | 108 | 5 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-04 | 200 | 108 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 200 | 108 | 5 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-04 | 200 | 108 | 5 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.27e-04 | 200 | 108 | 5 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-04 | 200 | 108 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.11e-06 | 196 | 107 | 8 | 4819_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 3632_UP | |
| Drug | hydroxymethylphosphonate | 2.19e-05 | 2 | 107 | 2 | CID000075795 | |
| Drug | 6-Chloropurine Riboside, 5'-Monophosphate | 2.19e-05 | 2 | 107 | 2 | DB03948 | |
| Drug | Mycophenolate mofetil | 2.19e-05 | 2 | 107 | 2 | DB00688 | |
| Drug | purinogen | 2.19e-05 | 2 | 107 | 2 | CID003081226 | |
| Drug | AC1L9X6T | 2.19e-05 | 2 | 107 | 2 | CID000477594 | |
| Drug | Mycophenolic acid | 2.19e-05 | 2 | 107 | 2 | DB01024 | |
| Drug | trimethyl phosphate | 3.34e-05 | 39 | 107 | 4 | CID000010541 | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 4227_DN | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 6774_UP | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 4.10e-05 | 197 | 107 | 7 | 284_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 7401_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 4160_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 4358_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 2228_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 6129_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 4691_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 5333_UP | |
| Drug | AC1L59F0 | 6.54e-05 | 3 | 107 | 2 | CID000220847 | |
| Drug | AC1L9X6Q | 6.54e-05 | 3 | 107 | 2 | CID000477593 | |
| Drug | oxanosine-5'-monophosphate | 6.54e-05 | 3 | 107 | 2 | CID000477551 | |
| Disease | Brody myopathy (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.54e-04 | 29 | 106 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.26e-04 | 152 | 106 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | colon cancer (is_implicated_in) | 2.95e-04 | 36 | 106 | 3 | DOID:219 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 3.13e-04 | 163 | 106 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.56e-04 | 99 | 106 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Peritoneal Neoplasms | 5.65e-04 | 10 | 106 | 2 | C0031149 | |
| Disease | Carcinomatosis of peritoneal cavity | 5.65e-04 | 10 | 106 | 2 | C0346990 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 5.73e-04 | 45 | 106 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.36e-04 | 49 | 106 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Congenital myopathy (disorder) | 8.24e-04 | 12 | 106 | 2 | C0270960 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 8.28e-04 | 51 | 106 | 3 | cv:CN043650 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 8.76e-04 | 52 | 106 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | colorectal cancer (is_implicated_in) | 9.68e-04 | 121 | 106 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 9.72e-04 | 13 | 106 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.30e-03 | 15 | 106 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Malignant neoplasm of endometrium | 1.88e-03 | 18 | 106 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 1.88e-03 | 18 | 106 | 2 | C0346191 | |
| Disease | Hereditary hearing loss and deafness | 1.93e-03 | 146 | 106 | 4 | cv:C0236038 | |
| Disease | melanoma | 2.05e-03 | 248 | 106 | 5 | C0025202 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 2.33e-03 | 20 | 106 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Autistic Disorder | 2.56e-03 | 261 | 106 | 5 | C0004352 | |
| Disease | epilepsy (biomarker_via_orthology) | 2.57e-03 | 21 | 106 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 2.57e-03 | 21 | 106 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | Nonsyndromic genetic hearing loss | 2.62e-03 | 76 | 106 | 3 | cv:C5680182 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 2.82e-03 | 22 | 106 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | Nonsyndromic Deafness | 3.14e-03 | 81 | 106 | 3 | C3711374 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKVRMQLQEARGEGE | 456 | Q9UPW8 | |
| KGEIQARNLGMAVEA | 456 | Q86V21 | |
| GESTDRLMGKGQVQL | 991 | P11274 | |
| LSKIAQGRGSQELGM | 586 | Q9Y6D6 | |
| KERMALEGIGIGSGQ | 151 | Q9H201 | |
| GQDNRKLLCGMAVGL | 81 | Q9NYM9 | |
| QVLRVKGADGMILGG | 191 | Q8NB90 | |
| VDMQKLLGGQIGLED | 86 | Q8TF64 | |
| VGRSKDMIIRGGENI | 506 | Q96CM8 | |
| EVMLQNDSRKGVIGG | 826 | Q5W041 | |
| LMDRDGNGKLGLVEF | 596 | P07384 | |
| GEDRKLFVGMLGKQQ | 131 | Q96J87 | |
| LFVGMLGKQQGEEDV | 136 | Q96J87 | |
| DAGIRVIMITGDNKG | 616 | O14983 | |
| QAGIRVVMITGDNKG | 616 | Q93084 | |
| IAMDGTEGLVRGQKV | 111 | P06576 | |
| RTGMDRGVGLTADQK | 86 | Q9H0I3 | |
| MQGERGGGAALKENV | 1531 | Q96L73 | |
| GRVQQIQLLGRDMKG | 216 | Q9HD26 | |
| QEGAKMAVRLAGGLQ | 266 | P35222 | |
| GLCQKAQLERMGVSG | 566 | Q96RG2 | |
| GIQGRGRQTVDKVMG | 801 | Q14676 | |
| MRKQEVRTGREAGQG | 1 | Q7RTR2 | |
| RMVKGGQEAGGQLRV | 2801 | Q9UKN7 | |
| KIEDAGMQLLCGGLR | 871 | P59045 | |
| QAKRMDEQRVDLAGG | 641 | Q86YR5 | |
| GIGMTKADLINNLGA | 66 | Q58FF6 | |
| KNLIDAGVDALRVGM | 311 | P12268 | |
| NAKIGGVRMLDGDVT | 236 | Q92824 | |
| GGVGALGIMNNRLAE | 411 | Q9HB15 | |
| RLAKGAQLNGRDAGM | 46 | Q9NQ69 | |
| DKMVGFIIGRGGEQI | 86 | Q96I24 | |
| LNGGRMKLTQTDELG | 246 | Q6AI08 | |
| AQVIKMLGNGRLEAL | 36 | O14602 | |
| LGDAGVGKSMLLQRL | 201 | Q9Y239 | |
| KINIQAMDGGGLSAR | 316 | Q9UN67 | |
| MGDIFKNNGVLQGRL | 1 | Q9Y6Z4 | |
| EGMRGAGLSCEQLKQ | 406 | Q8TEA1 | |
| LLMGEQLGNVARGIN | 96 | P58499 | |
| MGREQDLILAVKNGD | 1 | Q8WXE0 | |
| ERRTKGAGNMVNGLA | 266 | Q9HC58 | |
| KNLIDAGVDGLRVGM | 311 | P20839 | |
| SGQGEKAGMGQLREQ | 411 | Q2TAC6 | |
| IMLGVNQGEGLKFVE | 401 | Q9NZ94 | |
| DIMLGVNQGEGLKFV | 366 | Q8NFZ3 | |
| LTDGVGRREKGFQMQ | 1371 | O60494 | |
| LKGVVNAALGQEMGS | 321 | A0AVF1 | |
| QRGGKELGLRNSDMD | 301 | Q92743 | |
| GFGNLLAKQLVDRGM | 36 | Q8NEX9 | |
| GGFEQKMSRREAGLI | 86 | Q9Y5T4 | |
| EEGAAQMSLGQRAKL | 61 | P68106 | |
| KGERGERGDLQSQAM | 1601 | Q05707 | |
| MDRGSDGKLQEVGQV | 331 | P06756 | |
| SQMFEGQILDVKGGR | 1621 | Q8N1P7 | |
| QRGINAGADILMFEG | 1401 | Q8WXX0 | |
| NGDGKLGLSEMSRLL | 166 | P22676 | |
| MQAALLEKLVGGQAG | 771 | Q9Y6C2 | |
| EQLEGRNKMLQGPGR | 61 | A0A1B0GVR7 | |
| QNVDRAMAKLQGEGL | 71 | Q13268 | |
| MAFQDLLDQVGGLGR | 1 | Q6T423 | |
| LGQMDTKGLVRALGE | 346 | Q92503 | |
| TAGDMGKLRQIIQRG | 206 | P43246 | |
| DIMLGVNQGEGLKFV | 366 | Q8N0W4 | |
| FQIIGGEKMGRLDLG | 1106 | Q12923 | |
| KINIQAMDGGGLSAR | 316 | Q9Y5E1 | |
| TENGLMLLDRSGQGK | 1036 | Q8N4C8 | |
| MEGDKSQQLGRVVVG | 371 | Q9BQS2 | |
| DRLENMRKNVAGDGV | 81 | Q9Y2J0 | |
| GRGGELQKIGEFCMV | 91 | Q96AH0 | |
| DGEMNNLQIAIGRIK | 816 | P35499 | |
| VLRDMQQGLKDVGAN | 376 | O75069 | |
| MGDVEIGLQERNGQL | 116 | Q9H426 | |
| LQGLQEEGLDLGAQM | 591 | Q6ZMZ3 | |
| DLRGEGVKLQVMANS | 146 | Q15046 | |
| DKGMTNINDGLLRGI | 356 | Q06033 | |
| QEVNGSQRGKGILDM | 321 | Q7RTY7 | |
| GKVAEIMQNDRLGGL | 61 | Q5SGD2 | |
| GVLKNMSQRIGGELE | 181 | O43752 | |
| RDMKQGLLSVGIGGR | 936 | Q9Y2G9 | |
| KLIMGLDGTTQGLQR | 416 | Q9NUV7 | |
| RGQRLGELEEKTAGM | 1146 | Q9Y2K9 | |
| LAESERMQVLNGNGG | 826 | Q8WXI2 | |
| VTGRRIGNNFMDGLK | 41 | P51911 | |
| IGNNFMDGLKDGIIL | 46 | P51911 | |
| IGIMGKEGRQAARNS | 836 | Q9Y2G3 | |
| MDENQGKGIRVLGIA | 771 | Q7KZ85 | |
| QMEKQGDGFRALAGL | 851 | Q8TCY9 | |
| LLGGGMKQEDNAIIE | 166 | Q6DKK2 | |
| QKLGELNIGMDGLGN | 481 | O94967 | |
| PNRIQAGEIGEMKDG | 256 | P16989 | |
| QGLGAEVAKNLVLMG | 41 | P41226 | |
| DSQKIQLRIIGGDMA | 986 | O95428 | |
| AADVGAQMIKLVGLR | 156 | Q9H6E5 | |
| ETNQRKGVMGAGALL | 436 | Q96GP6 | |
| NGEMAVTRGQLKNGG | 331 | P10828 | |
| LLRMGLNDNKAGMEG | 16 | Q9UBT6 | |
| DGNREKIDVMGLLTG | 106 | Q9BZD6 | |
| GAMNGLRLGLKETQN | 91 | Q5SRD1 | |
| EQGIQDTKDVLGLMG | 171 | Q8NDW8 | |
| KGAREAGGQAQAMEL | 46 | Q96JG9 | |
| ATQREGNLGGKIQME | 71 | Q9UK10 | |
| REGNSGGKIQIEMET | 96 | Q9UK13 | |
| LIGLNLVMSRNAGKG | 81 | Q9BVK8 | |
| GAMNGLRLGLKETQN | 91 | O14925 | |
| MNVGRLQGFDGKIVA | 2146 | O75962 | |
| NSLEQGMVGLKIGDV | 181 | Q9BYJ9 | |
| EPQGRGLALQKMGQE | 261 | Q49AM3 | |
| IGTNLFGVLANKMGR | 351 | P54219 | |
| LDAKQAEAIMVRGQG | 21 | P07101 | |
| ASGINMIKLIREDGG | 171 | Q86TJ5 | |
| AVEMLKGQRADLGLQ | 806 | O94832 | |
| ELEVKGRGLNAMANE | 6016 | P20929 | |
| IGREGAMLKCLSEGQ | 261 | Q96NY8 |